Key facts
- This page summarizes Backstrom Jay T.'s Form 3 filing for LAVA Therapeutics NV (LVTX).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 02 Jan 2025, 09:28.
Backstrom Jay T. - 01 Jan 2025 Form 3 Insider Report for LAVA Therapeutics NV (LVTX)
- Reporting relationship
- Director
- Issuer ticker
- LVTX
- Reported as of
- 01 Jan 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 02 Jan 2025, 09:28:10 UTC
- Prior SEC filing
- 20 Feb 2024
- Next SEC filing
- 21 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amy Garabedian, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Backstrom Jay T. filed Form 3 for LAVA Therapeutics NV (LVTX) on 02 Jan 2025.
Change
- Previous filing in this sequence was filed on 20 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LVTX
holding
Derivative
Share Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 20,000
- Exercise price
- $3.64
- Footnotes
- F1
LVTX
holding
Derivative
Share Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 20,000
- Exercise price
- $3.60
- Footnotes
- F1
LVTX
holding
Derivative
Share Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 33,390
- Exercise price
- $1.59
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Fully vested and immediately exercisable.
Footnote F2
100% of the shares underlying the option will vest on January 19, 2025, provided the Reporting Person remains in a service relationship with the Issuer or a subsidiary of the Issuer on such vesting date.